Mandate

Vinge advises Industrifonden in connection with investment in Apica

June 29, 2011

Vinge has advised Stiftelsen Industrifonden in connection with an SEK 10 million investment in Apica. Apica tests, analyses, monitors and improves the performance of websites. The existing investor, KTH Chalmers Capital also participated in the issue which amounts in total to SEK 15 million. The funds will be used to finance the launch of Apica’s services in the US. Apica was founded in 2005 and has its head office in Stockholm and sales offices in Great Britain and the US.

Vinge’s team consisted of project manager Johan Larsson together with Tina Hård and Malin Buch. Johan Winnerbald was the responsible partner.

Related

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson to Citira, a European tire management provider and portfolio company of Norvestor. Headquartered in Stockholm, Malte Månson is an independent service and repair provider for commercial vehicles and operates a network of 28 service workshop locations across Sweden, authorized by brands such as MAN, DAF, IVECO, Mercedes-Benz, Setra, VDL and EVO. Malte Månson has an annual revenue of SEK 800 million and employs over 300 full-time professionals.
June 08, 2026

Vinge advises InArea on entering into a SEK 450 million credit agreement with SEB

InArea's new facilities agreement comprises a term loan and a revolving credit facility, replacing the company's existing facilities. The facilities agreement also includes an option to increase the lending framework through an incremental facility of up to SEK 200 million.
June 03, 2026

Vinge has advised the arrangers in connection with St1 Biokraft’s EUR 260 million financing

Vinge has advised the arrangers, ING Bank N.V., ABN AMRO Bank N.V., DNB Bank ASA, Nordea Bank Abp, OP Corporate Bank plc, Coöperatieve Rabobank U.A., SpareBank 1 Sør-Norge ASA and Swedbank AB, in connection with St1 Biokraft AB’s EUR 260 million financing.
June 03, 2026